LoboVault Home
 

Effect of Carelink, an Internet-Based Insulin Pump Monitoring System, on Glycemic Control in Children with Type 1 Diabetes Mellitus

LoboVault

Please use this identifier to cite or link to this item: http://hdl.handle.net/1928/3388

Effect of Carelink, an Internet-Based Insulin Pump Monitoring System, on Glycemic Control in Children with Type 1 Diabetes Mellitus

Show simple item record

dc.contributor.author Corriveau, Erin A.
dc.contributor.author Durso, Peter J.
dc.contributor.author Skipper, Betty J.
dc.contributor.author Kaufman, Ellen D.
dc.contributor.author Laskaratos, Louise A.
dc.contributor.author Heintzman, Kimberly B.
dc.date.accessioned 2007-10-14T02:47:34Z
dc.date.available 2007-10-14T02:47:34Z
dc.date.issued 2007-06-01
dc.identifier.uri http://hdl.handle.net/1928/3388
dc.description The records of 146 children with Type 1 diabetes treated with insulin pump therapy between 2004-2007 were reviewed. Glycemic control and diabetes self-care measures associated with the use of Carelink, an internet-based insulin pump monitoring system, were evaluated. Carelink users had significantly improved glycemic control. This was felt to be due to increased contact with a multidisciplinary diabetes team via the internet and improved blood sugar, insulin and carbohydrate records which were available to practitioners and parents with the use of the Carelink program. en
dc.description.abstract Objective : To determine whether use of the internet-based Carelink system improved glycemic control in children on insulin pump therapy. Research Design and Methods - We reviewed records of 146 children treated with insulin pump therapy between the years 2004-2007, and compared glycemic control and diabetes self-care measures associated with Carelink use. Forty percent of the patients resided one hour or more from our clinic. Results: Patients who used the Carelink software and website showed significant improvement in HbA1c levels following use (8.0 ± 0.1 (SE) vs 7.7 ± 0.1 (SE), p=0.002). They uploaded data from their pump and glucometer 2.2 ± 1.8 times per month over 0.8 ± 0.4 (SD) years. Patients who had no access to Carelink software and were followed in a conventional manner showed no change in HbA1c ( 8.0 ± 0.1 (SE) vs 8.1 ± 0.1 (SE), p=0.27) during the study period. These patients did not differ significantly from Carelink users in diabetes self care behaviors. Patients who had Carelink access but did not use it had a higher HbA1c level at the onset and did not change over the study period (HbA1c 8.9 ± 0.2 (SE) vs 8.9 ± 0.3 (SE), p=0.76). These patients differed significantly from Carelink users in self-care behaviors, but not in the frequency of blood glucose monitoring. Patients in a rural location benefited equally as compared to patients who lived within one hour of our clinic. Conclusions: The Carelink software program is a powerful tool that can be used by diabetes care providers and parents to manage insulin pump therapy in children and to improve glycemic control, especially in states with a large rural population. en_US
dc.description.sponsorship Presbyterian Healthcare Foundation and UNM School of Medicine Department of Family and Community Medicine en
dc.format.extent 489245 bytes
dc.format.mimetype application/pdf
dc.language.iso en_US en_US
dc.publisher Submitted for publication en_US
dc.subject type 1 diabetes en_US
dc.subject insulin pump therapy en_US
dc.subject nternet monitoring en_US
dc.subject glycemic control en_US
dc.title Effect of Carelink, an Internet-Based Insulin Pump Monitoring System, on Glycemic Control in Children with Type 1 Diabetes Mellitus en_US
dc.type Article en_US


Files in this item

Files Size Format View
CareLinkPersonalReports.pdf 477.7Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

UNM Libraries

Search LoboVault


Advanced Search

Browse

My Account